1-2 of 2
Izumi Wasada
Close
Sort by
Journal Articles

Prognostic Value Of LMP1, CLA, NK-Cell Origin, and Pretreatment Bone Marrow EBER-ISH In Localized NK/T-Cell Lymphoma Prospectively Treated With Concurrent Chemoradiotherapy: An Ancillary Study Of Japan Clinical Oncology Group (JCOG) 0211

Motoko Yamaguchi, MD, PhD, Katsuyoshi Takata, MD, PhD, Tadashi Yoshino, MD, PhD, Naoki Ishizuka, PhD, Masahiko Oguchi, MD, PhD, Yukio Kobayashi, MD, PhD, Yasushi Isobe, MD, PhD, Kenichi Ishizawa, MD, Nobuko Kubota, MD, PhD, Kuniaki Itoh, MD, PhD, Noriko Usui, MD, PhD, Kana Miyazaki, MD, PhD, Izumi Wasada, RN, Shigeo Nakamura, MD, PhD, Yoshihiro Matsuno, MD, PhD, Kazuo Oshimi, MD, PhD, Tomohiro Kinoshita, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Kensei Tobinai, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4280.
https://doi.org/10.1182/blood.V122.21.4280.4280
Published: 2013
Journal Articles

Phase I/II Study of Concurrent Chemoradiotherapy for Newly-Diagnosed, Localized Nasal NK/T-Cell Lymphoma: Results of a Phase I Portion of JCOG0211-DI.

Motoko Yamaguchi, Masahiko Oguchi, Kensei Tobinai, Nobuo Maseki, Takayo Suzuki, Yasufumi Masaki, Masanobu Nakata, Hiroyuki Hata, Noriko Usui, Izumi Wasada, Yoshikazu Kagami, Shigeo Nakamura, Tomomitsu Hotta, Kazuo Oshimi, The Japan Clinical Oncology Group - Lymphoma Study Group (JCOG-LSG) Japan.
Journal: Blood
Blood (2005) 106 (11): 2685.
https://doi.org/10.1182/blood.V106.11.2685.2685
Published: 2005